UPADACITINIB WAS NOT ASSOCIATED WITH ANAEMIA IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE U-ACHIEVE STUDY

被引：0
|
作者：
D'Haens, Geert R.
Hebuterne, Xavier
Higgins, Peter D.
Loftus, Edward V.
Zhou, Wen
Lacerda, Ana P.
Xie, Wangang
Liu, Jianzhong
Danese, Silvio
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1889
引用
收藏
页码：S1205 / S1206
页数：2
相关论文
共 50 条
  • [41] Mirikizumab Pharmacokinetics in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase III LUCENT Studies
    Chua, Laiyi
    Friedrich, Stuart
    Zhang, Xin Cindy
    CLINICAL PHARMACOKINETICS, 2023, : 1479 - 1491
  • [42] Mirikizumab Pharmacokinetics in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase III LUCENT Studies
    Chua, Laiyi
    Friedrich, Stuart
    Zhang, Xin Cindy
    CLINICAL PHARMACOKINETICS, 2023,
  • [43] Mirikizumab Pharmacokinetics in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase III LUCENT Studies
    Laiyi Chua
    Stuart Friedrich
    Xin Cindy Zhang
    Clinical Pharmacokinetics, 2023, 62 (10) : 1479 - 1491
  • [44] Identification of biomarkers and mechanistic insight for upadacitinib in ulcerative colitis: Analysis of serum inflammatory mediators in the phase 2b U-ACHIEVE study
    Vermeire, S.
    Guay, H.
    Verstockt, B.
    Fann, J.
    Cheng, J.
    Hong, F.
    Lee, W. J.
    Lacerda, A.
    Zhou, W.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S057 - S058
  • [45] Benefits of High versus Low Dose Upadacitinib as Maintenance Treatment in Ulcerative Colitis Patients Who Were Responders to 8-week Induction with Upadacitinib: Results From the U-ACHIEVE Phase 3 Maintenance Trial
    Feagan, Brian G.
    Parkes, Gareth
    Juillerat, Pascal
    Gecse, Krisztina
    Yao, Xuan
    Zhou, Wen
    Deng, Huiwen
    Ilo, Dapo
    Sanchez-Gonzalez, Yuri
    Higgins, Peter D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S496 - S496
  • [46] Efficacy of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis by Biologic Inadequate Responder Status: Results From Two Randomized Phase 3 Studies
    Vermeire, Severine
    Tanida, Satoshi
    Hu, Renwei
    Panaccione, Remo
    Hebuterne, Xavier
    Rubin, David T.
    Ilo, Dapo
    Zhou, Wen
    Weinreich, Michael
    Zhou, Qing
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S398 - S399
  • [47] Matching-adjusted indirect comparison of upadacitinib vs vedolizumab as induction therapy in patients with moderately to severely active ulcerative colitis
    Venugopal, K.
    Reinisch, W.
    Vermeire, S.
    Hedin, C.
    Rubin, D. T.
    Panes, J.
    Deng, H.
    Xuan, S.
    Wegrzyn, L.
    Liu, J.
    Ilo, D.
    Zhou, W.
    Gonzalez, Y. Sanchez
    Panaccione, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 135 - 135
  • [48] Matching-Adjusted Indirect Comparison of Upadacitinib versus Vedolizumab as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis
    Reinisch, Walter
    Vermeire, Severine
    Hedin, Charlotte
    Rubin, David T.
    Panes, Julian
    Deng, Huiwen
    Xuan, Si
    Wegrzyn, Lani
    Liu, John
    Ilo, Dapo
    Zhou, Wen
    Sanchez-Gonzalez, Yuri
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S520 - S521
  • [49] IDENTIFICATION OF BIOMARKERS AND MECHANISTIC INSIGHT FOR UPADACITINIB IN ULCERATIVE COLITIS: ANALYSIS OF SERUM INFLAMMATORY MEDIATORS IN THE PHASE 2B U-ACHIEVE STUDY
    Vermeire, Severine
    Guay, Heath M.
    Verstockt, Bram
    Fann, James
    Cheng, Jie
    Hong, Feng
    Lee, Wan-Ju
    Lacerda, Ana P.
    Zhou, Wen
    Danese, Silvio
    GASTROENTEROLOGY, 2020, 158 (06) : S1197 - S1197
  • [50] Benefits of high versus low dose upadacitinib as maintenance treatment in ulcerative colitis patients who were responders to 8-week induction with upadacitinib: Results from the U-ACHIEVE phase 3 maintenance trial
    Feagan, Brian
    Parkes, Gareth
    Juillerat, Pascal
    Gecse, Krisztina
    Yao, Xuan
    Zhou, Wen
    Deng, Huiwen
    Ilo, Dapo
    Gonzalez, Yuri Sanchez
    Higgins, Peter D. R.
    SWISS MEDICAL WEEKLY, 2023, 153 : 2S - 2S
12345